Imago BioSciences (NASDAQ: IMGO)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-18 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.490 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Imago BioSciences (NASDAQ: IMGO) through any online brokerage.
Other companies in Imago BioSciences’s space includes: Immunovant (NASDAQ:IMVT), Kezar Life Sciences (NASDAQ:KZR), Centessa Pharmaceuticals (NASDAQ:CNTA), Altimmune (NASDAQ:ALT) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Imago BioSciences (NASDAQ: IMGO) was reported by HC Wainwright & Co. on Friday, March 25, 2022. The analyst firm set a price target for 36.00 expecting IMGO to rise to within 12 months (a possible 154.42% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Imago BioSciences (NASDAQ: IMGO) is $14.15 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Imago BioSciences.
Imago BioSciences’s Q2 earnings are confirmed for Thursday, August 18, 2022.
There is no upcoming split for Imago BioSciences.
Imago BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.